AGO2 and glioma: Furthermore, we proved that in low concentration, pristimerin inhibited the viability of glioma cells through AGO2, and suppressed expression PTPN1 via a canonical miRNA-mediated silencing mechanism, while in high concentration, pristimerin induced apoptosis.